Effect of Qijiao Shengbai capsule for leukopenia and agranulemia patients with Qi and blood deficiency syndrome:a multi-center randomized controlled trial  

作　　者：ZHANG Ling 张玲(Hematol Dept,Dongzhimen Hosp,Beijing CM Univ,Beijing 100700)

机构地区：[1]Hematol Dept,Dongzhimen Hosp,Beijing CM Univ,Beijing 100700

出　　处：《China Medical Abstracts(Internal Medicine)》2022年第1期12-13,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To evaluate the efficacy and safety of Qijiao Shengbai Capsule(QJSBC)for leukopenia and agranulocytosis.Methods A 28 days'randomized,double-blind,placebo-controlled,multicenter,non-inferiority trial was conducted,with 55 patients randomized to treatment group and 57 patients to control group.In the control group,the patients were given Anduolin Capsules and QJSBC simulated placebo orally,whereas QJSBC and placenbo capsules were taken orally in the treatment group.

关 键 词：PATIENTS RANDOMIZED CAPSULE 

分 类 号：R259[医药卫生—中西医结合]